Institutional investors hold a majority ownership of BMY through the 73.35% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2014, these large investors purchased a net $9.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 6.1 Million shares of Bristol-Myers Squibb
BROWN ADVISORY LLC Bought 5.9 Million shares of Bristol-Myers Squibb
THE VANGUARD GROUP, INC. Bought 5.1 Million shares of Bristol-Myers Squibb